Published in Skin Pharmacol Physiol on July 19, 2006
The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol (2011) 1.40
Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1. J Biol Chem (2008) 1.33
Challenges and opportunities in dermal/transdermal delivery. Ther Deliv (2010) 1.32
Direct visualization of lipid domains in human skin stratum corneum's lipid membranes: effect of pH and temperature. Biophys J (2007) 1.11
Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res (2012) 1.11
Stimuli-responsive liposome fusion mediated by gold nanoparticles. ACS Nano (2010) 1.10
Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification? J Invest Dermatol (2010) 0.99
Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J (2010) 0.99
Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol (2014) 0.98
The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacol Physiol (2012) 0.93
Shaping of cutaneous function by encounters with commensals. J Physiol (2016) 0.91
Proton conductivity through the human TRPM7 channel and its molecular determinants. J Biol Chem (2008) 0.91
Hydrogel containing nanoparticle-stabilized liposomes for topical antimicrobial delivery. ACS Nano (2014) 0.89
Liposome-like Nanostructures for Drug Delivery. J Mater Chem B Mater Biol Med (2013) 0.87
Staphylococcus aureus induces hypoxia and cellular damage in porcine dermal explants. Infect Immun (2015) 0.84
Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.83
Dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation. J Invest Dermatol (2013) 0.81
Optogenetic and chemogenetic strategies for sustained inhibition of pain. Sci Rep (2016) 0.80
Skin Physiology of the Neonate and Infant: Clinical Implications. Adv Wound Care (New Rochelle) (2015) 0.80
The Ontogeny of Skin. Adv Wound Care (New Rochelle) (2014) 0.80
Stimuli responsive ionogels for sensing applications-an overview. Membranes (Basel) (2012) 0.80
Utilization of biodegradable polymeric materials as delivery agents in dermatology. Clin Cosmet Investig Dermatol (2014) 0.79
International guidelines for the in vivo assessment of skin properties in non-clinical settings: part 1. pH. Skin Res Technol (2012) 0.79
The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids. Int J Nanomedicine (2014) 0.79
A honey trap for the treatment of acne: manipulating the follicular microenvironment to control Propionibacterium acnes. Biomed Res Int (2013) 0.78
Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection. PLoS One (2015) 0.77
Seeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and Dermatitis. PLoS One (2016) 0.76
Decreased cutaneous resonance running time in cured leprosy subjects. Skin Pharmacol Physiol (2009) 0.76
Cutaneous delivery of α-tocopherol and lipoic acid using microemulsions: influence of composition and charge. J Pharm Pharmacol (2013) 0.76
A Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureus. PLoS One (2017) 0.75
Comparison of Standard Culture-Based Method to Culture-Independent Method for Evaluation of Hygiene Effects on the Hand Microbiome. MBio (2017) 0.75
Relation between pH in the Trunk and Face: Truncal pH Can Be Easily Predicted from Facial pH. Ann Dermatol (2016) 0.75
Evaluation of pH of Bathing Soaps and Shampoos for Skin and Hair Care. Indian J Dermatol (2014) 0.75
Usefulness of Sweat Management for Patients with Adult Atopic Dermatitis, regardless of Sweat Allergy: A Pilot Study. Biomed Res Int (2017) 0.75
The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci Rep (2016) 0.75
Assessment of Lemon Balm (Melissa officinalis L.) Hydrogels: Quality and Bioactivity in Skin Cells. Evid Based Complement Alternat Med (2015) 0.75
Comprehensive evaluation of carboxylated nanodiamond as a topical drug delivery system. Int J Nanomedicine (2016) 0.75
pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents. Pharmaceuticals (Basel) (2016) 0.75
Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel. Int J Nanomedicine (2016) 0.75
Design, characterization, and clinical evaluation of argan oil nanostructured lipid carriers to improve skin hydration. Int J Nanomedicine (2014) 0.75
Cholinergic induction of perspiration attenuates nonhistaminergic pruritus in the skin of patients with atopic dermatitis and healthy controls. Br J Dermatol (2015) 0.75
Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery. Ann Biomed Eng (2016) 0.75
Morphological Characteristics of Residual Skin Surface Components Collected from the Surface of Facial Skin in Women of Different Age. Ann Dermatol (2017) 0.75
Nanotechnology for the treatment of melanoma skin cancer. Prog Biomater (2017) 0.75
Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil. Br J Dermatol (1999) 1.96
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol Microbiol (1998) 1.70
Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol Microbiol (1999) 1.69
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin-independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br J Dermatol (2002) 1.42
[Pyoderma]. Hautarzt (1998) 1.37
Influence of serum protein binding on the in vitro activity of anti-fungal agents. Infection (1996) 1.23
Hyaluronic acid in the treatment and prevention of skin diseases: molecular biological, pharmaceutical and clinical aspects. Skin Pharmacol Physiol (2004) 1.19
Late cutaneous schistosomiasis representing an isolated skin manifestation of schistosoma mansoni infection. Dermatology (2000) 1.19
[Normal pH value of human skin]. Hautarzt (1986) 1.16
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect Immun (1993) 1.14
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study. Antimicrob Agents Chemother (1991) 1.13
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol (1995) 1.07
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol (2000) 1.07
Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6. Genitourin Med (1988) 1.02
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. J Invest Dermatol (2001) 0.99
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. Hautarzt (1989) 0.99
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. J Am Acad Dermatol (1990) 0.98
The role of vitamin E in normal and damaged skin. J Mol Med (Berl) (1995) 0.97
The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med (Berl) (1996) 0.96
Antimicrobial susceptibility testing of dermatophytes--comparison of the agar macrodilution and broth microdilution tests. Chemotherapy (1998) 0.96
Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro (2005) 0.95
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. Int J Antimicrob Agents (2001) 0.95
Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: an in vitro and in vivo study addressing acne vulgaris. Int J Cosmet Sci (2007) 0.95
Cefodizime penetration into skin suction blister fluid following a single intravenous dose. Eur J Clin Pharmacol (1986) 0.95
The KEX2 gene of Candida glabrata is required for cell surface integrity. Mol Microbiol (2001) 0.94
Onychomycosis. Mycoses (2007) 0.94
Aquarium dermatitis: cercarial dermatitis in an aquarist. Dermatology (1998) 0.93
Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects. Skin Pharmacol Physiol (2004) 0.92
Plasmid content and protein I serovar of non-penicillinase-producing gonococci isolated in Munich. Epidemiol Infect (1988) 0.92
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol (1999) 0.91
The use of systemic antimycotics in dermatotherapy. Eur J Dermatol (2000) 0.91
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release (2005) 0.90
Preputial abscesses caused by beta-lactamase-producing gonococci. Cutis (1985) 0.90
Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol (2006) 0.89
Liposomes: a drug carrier system for topical treatment in dermatology. Crit Rev Ther Drug Carrier Syst (1994) 0.89
[The correlation between biotype and antifungal sensitivity of Candida albicans]. Mykosen (1987) 0.89
Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. Acta Derm Venereol (1987) 0.88
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie (2005) 0.88
Phospholipases of Candida albicans. Mycoses (2001) 0.88
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich. Genitourin Med (1988) 0.87
Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years. Mycoses (1999) 0.87
HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses (1999) 0.87
Drug targeting by solid lipid nanoparticles for dermal use. J Drug Target (2002) 0.87
Human plasma and skin blister fluid levels of griseofulvin following a single oral dose. Eur J Clin Pharmacol (1985) 0.87
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G. Chemotherapy (1984) 0.86
Management of onychomycoses. Drugs (1999) 0.86
Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo. Chemotherapy (1984) 0.86
Prevalence of gonococci lacking the 2.6 megadalton cryptic plasmid. Lancet (1987) 0.85
Ketoconazole concentrations in human skin blister fluid and plasma. Int J Clin Pharmacol Ther Toxicol (1984) 0.85
Does cantharides blister fluid provide access to the peripheral compartment? Eur J Clin Pharmacol (1982) 0.85
Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol (2005) 0.85
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]. Mykosen (1986) 0.84
Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid. Acta Derm Venereol Suppl (Stockh) (1992) 0.84
Evaluation of cefotetan in uncomplicated gonorrhea. Dermatologica (1986) 0.84
Effect of iron limitation on protein composition and ultrastructure of Haemophilus ducreyi. FEMS Microbiol Lett (1990) 0.84
Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis. Mycoses (1994) 0.84
Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis. J Mol Med (Berl) (2000) 0.83
Innate immune receptors on neutrophils and their role in chronic lung disease. Eur J Clin Invest (2009) 0.83
Reflectance confocal microscopy in the diagnosis of partially and completely amelanotic melanoma: report on seven cases. J Eur Acad Dermatol Venereol (2012) 0.83
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. Skin Pharmacol (1992) 0.83
Penciclovir cream--improved topical treatment for herpes simplex infections. Skin Pharmacol Physiol (2004) 0.83
Dubowitz syndrome: atopic dermatitis, low birth weight dwarfism and facial dysmorphism. Dermatologica (1990) 0.83
Sunscreens - which and what for? Skin Pharmacol Physiol (2005) 0.83
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release (2004) 0.83
Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi. Int J STD AIDS (1997) 0.83
Liposomes for atopic dry skin: the rationale for a promising approach. Clin Investig (1993) 0.82
The secreted aspartic proteinases as a new target in the therapy of candidiasis. Curr Drug Targets (2002) 0.82
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. Int J Clin Pharmacol Ther (1995) 0.82
Human plasma and skin blister fluid levels of griseofulvin after its repeated administration. Eur J Clin Pharmacol (1985) 0.82
Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging. Skin Pharmacol Physiol (2004) 0.82
Absence of extracellular enzyme activity and cytotoxicity in cell-free culture filtrates of Haemophilus ducreyi. Microb Pathog (1991) 0.82
Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol (1992) 0.82
Distribution of auxotypes and correlation to antibiotic susceptibility of 169 recent clinical Neisseria gonorrhoeae isolates from Munich. Arch Dermatol Res (1983) 0.82
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. Mycoses (2006) 0.82
Intraindividual variations of 8-methoxypsoralen plasma levels. Arch Dermatol Res (1982) 0.82
Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles. Br J Dermatol (1996) 0.82
Fifty-kDa hyaluronic acid upregulates some epidermal genes without changing TNF-α expression in reconstituted epidermis. Skin Pharmacol Physiol (2011) 0.81
Soluble interleukin-2 receptors in serum and urine of patients with chancroid and their response to therapy. Int J STD AIDS (1990) 0.81
The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers. Dermatology (1995) 0.81
Antifungal susceptibility testing with dermatophytes. Mycoses (1992) 0.81
Glucocorticoids for human skin: new aspects of the mechanism of action. Skin Pharmacol Physiol (2005) 0.81
Comparative therapeutic and toxic effects of different povidone iodine (PVP-I) formulations in a model of oral candidosis based on in vitro reconstituted epithelium. J Drug Target (2001) 0.81
[Coincidence of multiple cylindroma and trichoepitheliomas (Brooke-Spiegler-Syndrome)]. Hautarzt (1982) 0.80
Use of a transport medium in the search for Salmonella carriers--is it worthwhile? Med Microbiol Immunol (1980) 0.80
Nicotinamide - biologic actions of an emerging cosmetic ingredient. Int J Cosmet Sci (2005) 0.80
Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. J Med Microbiol (2001) 0.80
The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacol Physiol (2009) 0.80
Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea. Int J Clin Pharmacol Ther Toxicol (1984) 0.80
The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role. Eur J Med Res (2002) 0.80
Toxicity and antimicrobial activity of a hydrocolloid dressing containing silver particles in an ex vivo model of cutaneous infection. Skin Pharmacol Physiol (2004) 0.80
Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis. Skin Pharmacol Physiol (2008) 0.80
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound. Acta Derm Venereol (1992) 0.80
Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug design. Int J Antimicrob Agents (2005) 0.80
[Cephalosporin allergy and cephalosporin-penicillin cross allergies with special reference to venereologic therapy of severe anaphylactic reactions]. Hautarzt (1984) 0.80
Tinea capitis: ringworm of the scalp. Mycoses (2007) 0.80
Successful treatment of griseofulvin-resistant tinea capitis in infants. Mycoses (1995) 0.80
Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age. Pharmazie (1999) 0.80
Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro. Pharm Res (1997) 0.79
Identification of dermatophytes by Fourier transform infrared spectroscopy (FT-IR). Mycoses (1999) 0.79